ID   MCR_RAT                 Reviewed;         981 AA.
AC   P22199; Q63763; Q64174;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   02-OCT-2024, entry version 190.
DE   RecName: Full=Mineralocorticoid receptor;
DE            Short=MR;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 2;
GN   Name=Nr3c2; Synonyms=Mlr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RX   PubMed=2558305; DOI=10.1210/mend-3-11-1877;
RA   Patel P.D., Sherman T.G., Goldman D.J., Watson S.J.;
RT   "Molecular cloning of a mineralocorticoid (type I) receptor complementary
RT   DNA from rat hippocampus.";
RL   Mol. Endocrinol. 3:1877-1885(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 597-679 (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7495694; DOI=10.1016/0960-0760(95)00162-s;
RA   Bloem L.J., Guo C., Pratt J.H.;
RT   "Identification of a splice variant of the rat and human mineralocorticoid
RT   receptor genes.";
RL   J. Steroid Biochem. Mol. Biol. 55:159-162(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 688-787 (ISOFORM 1).
RC   STRAIN=Wistar; TISSUE=Cochlea;
RX   PubMed=7982810; DOI=10.1016/0378-5955(94)90023-x;
RA   Furuta H., Mori N., Sato C., Hoshikawa H., Sakai S., Iwakura S., Doi K.;
RT   "Mineralocorticoid type I receptor in the rat cochlea: mRNA identification
RT   by polymerase chain reaction (PCR) and in situ hybridization.";
RL   Hear. Res. 78:175-180(1994).
RN   [4]
RP   HOMODIMERIZATION, HETERODIMERIZATION WITH NR3C1, AND MUTAGENESIS OF ARG-643
RP   AND ASP-645.
RX   PubMed=8618925; DOI=10.1073/pnas.92.26.12480;
RA   Liu W., Wang J., Sauter N.K., Pearce D.;
RT   "Steroid receptor heterodimerization demonstrated in vitro and in vivo.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:12480-12484(1995).
RN   [5]
RP   INTERACTION WITH NCOA2.
RX   PubMed=9111344; DOI=10.1128/mcb.17.5.2735;
RA   Hong H., Kohli K., Garabedian M.J., Stallcup M.R.;
RT   "GRIP1, a transcriptional coactivator for the AF-2 transactivation domain
RT   of steroid, thyroid, retinoid, and vitamin D receptors.";
RL   Mol. Cell. Biol. 17:2735-2744(1997).
RN   [6]
RP   PHOSPHORYLATION.
RX   PubMed=9677313; DOI=10.1042/bj3330555;
RA   Galigniana M.D.;
RT   "Native rat kidney mineralocorticoid receptor is a phosphoprotein whose
RT   transformation to a DNA-binding form is induced by phosphatases.";
RL   Biochem. J. 333:555-563(1998).
RN   [7]
RP   IDENTIFICATION OF ISOFORM 3.
RX   PubMed=10687858; DOI=10.1016/s0303-7207(99)00198-7;
RA   Zhou M.-Y., Gomez-Sanchez C.E., Gomez-Sanchez E.P.;
RT   "An alternatively spliced rat mineralocorticoid receptor mRNA causing
RT   truncation of the steroid binding domain.";
RL   Mol. Cell. Endocrinol. 159:125-131(2000).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283 AND SER-287, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Receptor for both mineralocorticoids (MC) such as aldosterone
CC       and glucocorticoids (GC) such as corticosterone or cortisol. Binds to
CC       mineralocorticoid response elements (MRE) and transactivates target
CC       genes. The effect of MC is to increase ion and water transport and thus
CC       raise extracellular fluid volume and blood pressure and lower potassium
CC       levels.
CC   -!- SUBUNIT: Heteromultimeric cytoplasmic complex with HSP90, HSP70, and
CC       FKBP4, in the absence of ligand. After ligand binding, it translocates
CC       to the nucleus and binds to DNA as a homodimer and as a heterodimer
CC       with NR3C1. Binds the coactivator NCOA2. May interact with HSD11B2 in
CC       the absence of ligand. Binds the coactivators NCOA1, TIF1 and NRIP1 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00407}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Note=Cytoplasmic and nuclear in the absence of ligand; nuclear after
CC       ligand-binding. When bound to HSD11B2, it is found associated with the
CC       endoplasmic reticulum membrane (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P22199-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P22199-2; Sequence=VSP_003705;
CC       Name=3;
CC         IsoId=P22199-3; Sequence=VSP_007361, VSP_007362;
CC   -!- TISSUE SPECIFICITY: Detected in liver, brain, heart, kidney, colon,
CC       aorta, hippocampus, hypothalamus and adrenal fasciculata.
CC       {ECO:0000269|PubMed:7495694}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Phosphorylated. {ECO:0000269|PubMed:9677313}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Very low transactivation activity, not
CC       increased by aldosterone. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M36074; AAA41583.1; -; mRNA.
DR   EMBL; S79920; AAB35738.1; -; mRNA.
DR   EMBL; S75686; AAB32663.2; -; mRNA.
DR   PIR; A41401; A41401.
DR   RefSeq; NP_037263.1; NM_013131.1.
DR   AlphaFoldDB; P22199; -.
DR   SMR; P22199; -.
DR   BioGRID; 247701; 1.
DR   STRING; 10116.ENSRNOP00000045942; -.
DR   BindingDB; P22199; -.
DR   ChEMBL; CHEMBL3507; -.
DR   DrugCentral; P22199; -.
DR   GuidetoPHARMACOLOGY; 626; -.
DR   iPTMnet; P22199; -.
DR   PhosphoSitePlus; P22199; -.
DR   PaxDb; 10116-ENSRNOP00000045942; -.
DR   GeneID; 25672; -.
DR   KEGG; rno:25672; -.
DR   UCSC; RGD:3094; rat. [P22199-1]
DR   AGR; RGD:3094; -.
DR   CTD; 4306; -.
DR   RGD; 3094; Nr3c2.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; P22199; -.
DR   OrthoDB; 5350431at2759; -.
DR   PhylomeDB; P22199; -.
DR   Reactome; R-RNO-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-RNO-4090294; SUMOylation of intracellular receptors.
DR   PRO; PR:P22199; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IDA:SynGO.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0034056; F:estrogen response element binding; IBA:GO_Central.
DR   GO; GO:0035035; F:histone acetyltransferase binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0003707; F:nuclear steroid receptor activity; IMP:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0005496; F:steroid binding; IMP:RGD.
DR   GO; GO:0017025; F:TBP-class protein binding; ISO:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; ISO:RGD.
DR   GO; GO:1904045; P:cellular response to aldosterone; IMP:RGD.
DR   GO; GO:0031958; P:corticosteroid receptor signaling pathway; IDA:RGD.
DR   GO; GO:0006883; P:intracellular sodium ion homeostasis; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; IMP:RGD.
DR   GO; GO:0030518; P:nuclear receptor-mediated steroid hormone signaling pathway; IBA:GO_Central.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0055075; P:potassium ion homeostasis; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0002017; P:regulation of blood volume by renal aldosterone; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0035812; P:renal sodium excretion; ISO:RGD.
DR   GO; GO:0097305; P:response to alcohol; IEP:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IDA:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   CDD; cd07172; NR_DBD_GR_PR; 1.
DR   CDD; cd07075; NR_LBD_MR; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050200; Nuclear_hormone_rcpt_NR3.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR48092; KNIRPS-RELATED PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48092:SF19; MINERALOCORTICOID RECEPTOR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; DNA-binding; Endoplasmic reticulum;
KW   Lipid-binding; Membrane; Metal-binding; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Steroid-binding; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..981
FT                   /note="Mineralocorticoid receptor"
FT                   /id="PRO_0000053685"
FT   DOMAIN          723..961
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        604..669
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         604..624
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         640..664
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..603
FT                   /note="Modulating"
FT   REGION          234..331
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          355..376
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          670..722
FT                   /note="Hinge"
FT   REGION          684..710
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          779..782
FT                   /note="Important for coactivator binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        689..703
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         604
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         607
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         621
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         624
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         640
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         646
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         656
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         659
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         767
FT                   /ligand="21-hydroxyprogesterone"
FT                   /ligand_id="ChEBI:CHEBI:16973"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         767
FT                   /ligand="aldosterone"
FT                   /ligand_id="ChEBI:CHEBI:27584"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         767
FT                   /ligand="progesterone"
FT                   /ligand_id="ChEBI:CHEBI:17026"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         773
FT                   /ligand="21-hydroxyprogesterone"
FT                   /ligand_id="ChEBI:CHEBI:16973"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         773
FT                   /ligand="aldosterone"
FT                   /ligand_id="ChEBI:CHEBI:27584"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         773
FT                   /ligand="progesterone"
FT                   /ligand_id="ChEBI:CHEBI:17026"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         814
FT                   /ligand="21-hydroxyprogesterone"
FT                   /ligand_id="ChEBI:CHEBI:16973"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         814
FT                   /ligand="aldosterone"
FT                   /ligand_id="ChEBI:CHEBI:27584"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         814
FT                   /ligand="progesterone"
FT                   /ligand_id="ChEBI:CHEBI:17026"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         942
FT                   /ligand="21-hydroxyprogesterone"
FT                   /ligand_id="ChEBI:CHEBI:16973"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         942
FT                   /ligand="aldosterone"
FT                   /ligand_id="ChEBI:CHEBI:27584"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   BINDING         942
FT                   /ligand="progesterone"
FT                   /ligand_id="ChEBI:CHEBI:17026"
FT                   /evidence="ECO:0000250|UniProtKB:P08235"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VII8"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VII8"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VII8"
FT   VAR_SEQ         634
FT                   /note="G -> GKCSW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7495694"
FT                   /id="VSP_003705"
FT   VAR_SEQ         783..807
FT                   /note="VLPGFKNLPLEDQITLIQYSWMCLS -> NLKTCLSRTKSPSSSILGCVYHR
FT                   SL (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_007361"
FT   VAR_SEQ         808..981
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_007362"
FT   MUTAGEN         643
FT                   /note="R->D: Lowers homodimerization and decreases receptor
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8618925"
FT   MUTAGEN         645
FT                   /note="D->R: Lowers homodimerization and decreases receptor
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8618925"
FT   CONFLICT        688
FT                   /note="E -> K (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        771
FT                   /note="A -> G (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        775
FT                   /note="I -> S (in Ref. 3)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   981 AA;  106737 MW;  184F5D37C1B030F7 CRC64;
     METKGYHSLP EGLDMERRWS QVSQTLERSS LGPAERTTEN NYMEIVNVSC VSGAIPNNST
     QGSSKEKHEL LPYIQQDNSR SGILPSDIKT ELESKELSAT VAESMGLYMD SVRDAEYTYD
     QQNQQGSLSP TKIYQNMEQL VKFYKENGHR SSTLSAMSRP LRSFMPDSAA SMNGGALRAI
     VKSPIICHEK SSSVSSPLNM ASSVCSPVGI NSMSSSTTSF GSFPVHSPIT QGTSLTCSPS
     VENRGSRSHS PTHASNVGSP LSSPLSSMKS PISSPPSHCS VKSPVSSPNN VPLRSSVSSP
     ANLNNSRCSV SSPSNNTNNR STLSSPTAST VGSIGSPISN AFSYATSGAS AGAGAIQDVV
     PSPDTHEKGA HDVPFPKTEE VEKAISNGVT GPLNIVQYIK SEPDGAFSSS CLGGNSKISP
     SSPFSVPIKQ ESSKHSCSGA SFKGNPTVNP FPFMDGSYFS FMDDKDYYSL SGILGPPVPG
     FDGSCEDSAF PVGIKQEPDD GSYYPEASIP SSAIVGVNSG GQSFHYRIGA QGTISLSRSP
     RDQSFQHLSS FPPVNTLVES WKPHGDLSSR RSDGYPVLEY IPENVSSSTL RSVSTGSSRP
     SKICLVCGDE ASGCHYGVVT CGSCKVFFKR AVEGQHNYLC AGRNDCIIDK IRRKNCPACR
     LQKCLQAGMN LGARKSKKLG KLKGLHEEQP QQPPPPPPQS PEEGTTYIAP TKEPSVNSAL
     VPQLTSITHA LTPSPAMILE NIEPETVYAG YDNSKPDTAE SLLSTLNRLA AKQMIQVVKW
     AKVLPGFKNL PLEDQITLIQ YSWMCLSSFA LSWRSYKHTN SQLLYFAPDL VFNEEKMHQS
     AMYELCQGMR QISLQFVRLQ LTFEEYSIMK VLLLLSTVPK DGLKSQAAFE EMRTNYIKEL
     RKMVTKCPNS SGQSWQRFYQ LTKLLDSMHD LVSDLLEFCF YTFRESQALK VEFPAMLVEI
     ITDQLPKVES GNAKPLYFHR K
//
